Overall, the present findings suggest the therapeutic benefit of HDACi, acetate on metabolic dysregulation and ovarian mitochondrial dysfunction in PCOS rat model, which is accompanied by mitochondrial fusion protein MFn2 enhancement. Here, MFN2 is linked to polycystic ovary syndrome.